[Where are the grafts in Parkinson's disease?]

Insights

Transplants for Parkinson's disease showed some benefits but involved significant risks. Recent studies suggest the efficacy is less impressive than initially reported, questioning the procedure's overall value.

Area of Science:

  • Neuroscience
  • Transplantation Medicine
  • Neurological Surgery

Context:

  • International interest in Parkinson's disease transplants surged in the 1980s following a notable report.
  • Research groups worldwide have since attempted to replicate and improve upon transplant outcomes.
  • Early promising results for adrenal medullary transplants to the caudate nucleus have been tempered by further investigation.

Purpose:

  • To evaluate the efficacy and risks associated with adrenal medullary transplants for Parkinson's disease.
  • To review the progression of research and clinical interest in Parkinson's disease transplantation since the late 1980s.

Summary:

  • Adrenal medullary transplantation into the caudate nucleus has demonstrated some benefits for Parkinson's disease patients.
  • However, the procedure carries considerable risks.
  • Current evidence indicates that the therapeutic benefits are less pronounced than originally suggested by initial reports.

Impact:

  • The findings necessitate a re-evaluation of adrenal medullary transplantation as a viable treatment for Parkinson's disease.
  • Highlights the importance of rigorous, long-term studies to validate novel therapeutic interventions.
  • Underscores the need for careful risk-benefit analysis in surgical treatments for neurodegenerative disorders.

Related Concept Videos

Neural Regulation01:47

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...